Ocugen director granted 170,100 stock options
Ocugen, Inc. director Uday Kompella received a grant of stock options covering 170,100 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Ocugen, Inc. director Uday Kompella received a grant of stock options covering 170,100 shares of common stock. The options have an exercise price of $1.22 per share and expire on June 11, 2036.
The award vests upon the earlier of June 11, 2027 or Ocugen’s next annual meeting of stockholders, provided he continues serving through the vesting date. Following this grant, Kompella holds 170,100 options directly.
Insider Trade Summary
Grant/Award: 170,100 shares
Grant/Award
1 txn
Insider
Kompella Uday
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 170,100 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 170,100 contracts (Direct)
Footnotes (1)
- F1. The option vests upon the earlier of (a) June 11, 2027 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date.
Key Figures
Option grant size: 170,100 options
Exercise price: $1.22/share
Expiration date: June 11, 2036
+3 more
6 metrics
Option grant size
170,100 options
Stock Option (Right to Buy) granted to director
Exercise price
$1.22/share
Conversion or exercise price of the options
Expiration date
June 11, 2036
Option term end for granted award
Vesting date trigger
June 11, 2027 or next annual meeting
Earlier date determines vesting, subject to continued service
Options held after grant
170,100 options
Total derivative securities following transaction, direct ownership
Transaction price per option
$0.00
Grant/award acquisition, no purchase price paid
Key Terms
Stock Option (Right to Buy), exercise price, expiration date, vests, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "1.2200""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-06-11T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vests financial
"The option vests upon the earlier of (a) June 11, 2027 or (b) Ocugen, Inc.'s next annual meeting"
annual meeting of stockholders financial
"Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Ocugen (OCGN) director Uday Kompella report on this Form 4?
Uday Kompella reported receiving a grant of stock options for 170,100 shares of Ocugen common stock. These options are a compensation-related award, not an open-market stock purchase or sale, and are held directly under his name according to the filing.
What is the exercise price of the Ocugen (OCGN) options granted to Uday Kompella?
The granted options have an exercise price of $1.22 per share. This means Kompella can buy Ocugen common stock at $1.22 per share once vested and exercisable, regardless of the market price at that time, subject to the award terms.
When do Uday Kompella’s Ocugen (OCGN) stock options vest?
The options vest on the earlier of June 11, 2027 or Ocugen’s next annual meeting of stockholders. Vesting is conditioned on Kompella’s continued service with the company through whichever vesting date occurs first, as disclosed in the footnote.
When do the Ocugen (OCGN) stock options granted to Uday Kompella expire?
The options expire on June 11, 2036. After this expiration date, any unexercised portion of the 170,100 stock options can no longer be used to purchase Ocugen common shares at the $1.22 exercise price specified in the award.
Is this Ocugen (OCGN) Form 4 a buy or sell of common stock?
This Form 4 reports a grant of stock options, categorized as an acquisition, not a market buy or sell of common shares. Kompella received 170,100 options as a compensation award, with no open-market trading reported in this particular filing.
How many Ocugen (OCGN) options does Uday Kompella hold after this transaction?
After the reported grant, Kompella holds 170,100 stock options directly. The filing shows this as his total derivative holdings following the transaction, all tied to options exercisable into Ocugen common stock at an exercise price of $1.22 per share.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates